Practical Biostatistics

Part 1: The Investigator's Hypothesis 1. Investigator's Hypothesis and Expression of its Corresponding Outcome

Part 2: Collective Health 2. Disease Frequency Measures 3. Health Indicators 4. Epidemiological Studies 5. Pharmacoeconomics

Part 3: Observational Studies 6. Basic Concepts in Observational Studies 7. Determination of Association Strength Between an Exposure Factor and an Event in Observational Studies 8. Increasing Accuracy in Observational Studies

Part 4: Biostatistics of Intervention Studies - The Clinical Trials 9. The Intervention Studies 10. N Estimation and N Assessment of a Published Trial 11. Organization of Variables and Endpoints 12. Measures for Results Expression of a Clinical Trial 13. Determination of Normality or Non-Normality of Data Distribution 14. Hypothesis Testing 15. Correlating Sample Data with the General Population - 95% Confidence Interval Summarizing the Steps

Part 5: Additional Concepts in Biostatistics 16. Individual and Collective Benefit and Risk Indexes Inferable from Intervention Studies 17. Statistical Assessment of Diagnostic Tests for the Clinic 18. Systematic Reviews and Meta-Analyses 19. Correlation and Regression 20. Per Protocol Analysis and Intention-to-Treat Analysis

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Bioinformática medica
• Os ensaios clínicos
• Farmacologia
• Genética (não médica)

Absolute benefit increase; Absolute risk increase; Absolute risk reduction; Alternative hypothesis; Artificial pairing; Basal risk; Benefit indexes; Case-control studies; Categorical variables; Central tendency measures; Coefficient of determination; Coefficient of variation; Cohort prevalence study; Cohort studies; Comparative studies; Confidence interval; Confidence limits; Continuous variables; Controlled studies; Correlation; Cost-oriented timing; Costs minimization analysis; Costs standardization; Cost-benefit analysis; Cost-consequence analysis; Cost-efficacy grid; Cost-efficacy increment ratio; Cost-efficacy plan; Cost-efficacy ratio; Cost-efficacy ratio for percentual of an additional success; Cost-efficacy ratio for percentual unit of success; Cost-utility analysis; Covariates; Critial ratio; Cross-sectional studies; Crossover studies; Crude mortality rate; Cumulative incidence; Decision analysis; Degrees of freedom; Dependent samples; Dependent samples studies; Dependent variable; Dichotomous variables; Discount; Discrete variables; Dispersal measures; Double-blind studies; Drop-outs; Ecological studies; Effect size; Endpoints; Epidemiological studies; Forest plot; Gauss curve; Health-related life quality; Heterogeneity analysis; Human capital; Incidence; Incidence rate; Independent samples; Independent samples studies; Independent variable; Institutional costs; Intention-to-treat analysis; Interquartile range; Interval variables; Investigator's hypothesis; Lethality rate; Life expectancy; Likelihood of being helped versus harmed; Likelihood ratio; Linear regression formula; Longitudinal studies; Mann-Whitney test; Mean; Median; Meta-analysis; Meta-analysis weighted mean; Meta-regression analysis; Mode; Mortality; Mortality proportion; Mortality proportion due to cause of death; Mortality rate due to cause of death; Multiple linear regression; Multivariable analysis; N estimation; Natural pairing; Negative predictive value; Nominal variables; Noncomparative studies; Nondichotomous variables; Nonnormal distribution; Nonpaired samples studies; Nonparametric tests; Nonrandomized studies; Normal distribution; Null hypothesis; Number needed to harm